|
Press Releases |
|
|
|
Thursday, September 17, 2020 |
|
Dyadic Announces Collaboration with Jiangsu Hengrui Medicine for Biologic Drug Development |
Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ:DYAI), a global biotechnology company focused on further applying its proprietary C1 gene expression platform to accelerate development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales, today announced collaboration with Jiangsu Hengrui Medicine Co., Ltd. ("Hengrui") (SSE:600276) to apply Dyadic's C1 technology to the development of selected Hengrui biologic drug(s). more info >> |
|
Dyadic宣布與江蘇恆瑞醫藥合作開發生物藥物 |
全球生物技術公司Dyadic 國際股份有限公司(以下簡稱“ Dyadic”或“公司”)(納斯達克股票代碼:DYAI)一直致力於改進和應用其專有的C1基因表達平台,加速生物疫苗、藥物和其他生物製品的開發、降低生產成本並改善其性能,具有靈活的商業規模。今天宣布與江蘇恆瑞醫藥有限公司(“恆瑞”)(SSE:600276)合作,將Dyadic的C1技術應用於選定的恆瑞生物藥物的開發中。 more info >> |
|
Dyadic宣布与江苏恒瑞医药合作开发生物药物 |
全球生物技术公司Dyadic 国际股份有限公司(以下简称“ Dyadic”或“公司”)(纳斯达克股票代码:DYAI)一直致力于改进和应用其专有的C1基因表达平台,加速生物疫苗、药物和其他生物制品的开发、降低生产成本并改善其性能,具有灵活的商业规模。今天宣布与江苏恒瑞医药有限公司(“恒瑞”)(SSE:600276)合作,将Dyadic的C1技术应用于选定的恒瑞生物药物的开发中。 more info >> |
|
Tuesday, March 31, 2020 |
|
Dyadic宣布與藥明生物達成非排他性研究許可協議 |
全球生物技術公司Dyadic國際股份有限公司(以下簡稱“ Dyadic”或“公司”)(納斯達克股票代碼:DYAI)一直致力於改進和應用其專有的C1基因表達平台,加速生物疫苗、藥物和其他生物製品的開發、降低生產成本並改善其性能,具有靈活的商業規模。公司今天宣布,它已與全球領先的開放式生物製品技術平台公司及醫藥合同定制研發生產企業(CDMO)——藥明生物攜手,共同進行非排他性研究合作。 more info >> |
|
Dyadic宣布与药明生物达成非排他性研究许可协议 |
全球生物技术公司Dyadic国际股份有限公司(以下简称“ Dyadic”或“公司”)(纳斯达克股票代码:DYAI)一直致力于改进和应用其专有的C1基因表达平台,加速生物疫苗、药物和其他生物制品的开发、降低生产成本并改善其性能,具有灵活的商业规模。公司今天宣布,它已与全球领先的开放式生物制品技术平台公司及医药合同定制研发生产企业(CDMO)——药明生物携手,共同进行非排他性研究合作。 more info >> |
|
Monday, March 30, 2020 |
|
Dyadic Announces Nonexclusive Research License with WuXi Biologics |
Dyadic International, Inc. (NASDAQ:DYAI) today announced that it has entered into a nonexclusive research collaboration with WuXi Biologics, a leading global open-access biologics technology platform company and Contract Development and Manufacturing Organization. more info >> |
|
Thursday, May 9, 2019 |
|
Dyadic攜手印度血清研究所 Serum研發和製造 全球廣泛使用且可負擔得起的抗體產品和疫苗 |
Dyadic國際股份有限公司(以下簡稱''Dyadic'')(納斯達克:DYAI)專注於深入改善和應用旗下專利級C1基因表達平台來加速生物疫苗、藥物和其他生物產品的開發進程,降低生產成本,改善效用,推動靈活的商用普及。 more info >> |
|
Dyadic携手印度血清研究所 Serum研发和制造 全球广泛使用且可负担得起的抗体产品和疫苗 |
Dyadic国际股份有限公司(以下简称''Dyadic'')(纳斯达克:DYAI)专注于深入改善和应用旗下 专利级C1基因表达平台来加速生物疫苗、药物和其他生物产品的开发进程,降低生产成本,改善效用,推动灵活的商用普及。 more info >> |
|
Dyadic and Serum Institute of India to Develop and Manufacture Globally Affordable and Accessible Antibody Products and Vaccines |
Dyadic International, Inc. is pleased to announce a research and commercialization collaboration with Serum Institute of India Pvt., Ltd, one of the world's largest vaccine manufacturers, to develop and manufacture up to twelve antibodies and vaccines using Dyadic's C1 gene expression platform. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
LQR House Inc. Reports 424.58% Year-Over-Year Revenue Growth in October 2024 Compared to October 2023
Nov 4, 2024 22:00 HKT/SGT
|
|
|
With interest rate cuts taking effect, CWT hopes to take advantage of the favorable macro trend
Nov 4, 2024 20:00 HKT/SGT
|
|
|
Will New Gonow Recreational Vehicles Make It the Next Thor Industries?
Nov 4, 2024 20:00 HKT/SGT
|
|
|
香港傷殘青年協會副主席何雪梅:曹操出行無障礙專車值得向國際推廣
Nov 4, 2024 18:11 HKT/SGT
|
|
|
香港伤残青年协会副主席何雪梅:曹操出行无障碍专车值得向国际推广
Nov 4, 2024 18:02 HKT/SGT
|
|
|
HEROWORKS Embarks on Global Expansion with Hotel Revenue Management System
Nov 4, 2024 18:00: JST
|
|
|
HEROWORKS Embarks on Global Expansion with Hotel Revenue Management System
Nov 4, 2024 17:00 HKT/SGT
|
|
|
JBM Healthcare Limited Issues Positive Profit Alert
Nov 4, 2024 15:00 HKT/SGT
|
|
|
Asahi Kasei and Honda Sign Shareholders' Agreement to Convert Existing Asahi Kasei Subsidiary into Joint Venture for Production of Lithium-ion Battery Separators in Canada
Nov 4, 2024 14:12 JST
|
|
|
華邦科技成員成功舉辦「港灣家族辦公室2024香港高峰論壇」
Nov 4, 2024 12:19 HKT/SGT
|
|
|
GTJAI was selected into the first batch of qualified securities companies for the 'Cross-boundary Wealth Management Pilot Scheme'
Nov 4, 2024 10:58 HKT/SGT
|
|
|
國泰君安國際入選「跨境理財通」首批合資格證券公司
Nov 4, 2024 10:55 HKT/SGT
|
|
|
国泰君安国际入选“跨境理财通”首批合资格证券公司
Nov 4, 2024 10:51 HKT/SGT
|
|
|
Joby Aviation and Toyota Accelerate Efforts to Realize Air Mobility
Nov 4, 2024 9:36 JST
|
|
|
Autumn Lighting Fair, Outdoor and Tech Light Expo and Eco Expo Asia draw some 60,000 buyers
Nov 3, 2024 12:46 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|